6/19/2019  5:36:15 PM Chg. +0.045 Volume Bid6/19/2019 Ask6/19/2019 Market Capitalization Dividend Y. P/E Ratio
1.005EUR +4.69% 18,480
Turnover: 18,540.410
-Bid Size: - -Ask Size: - 51.93 mill.EUR 0.00% -

Business description

The Company focuses on the development of novel products in molecular biology, with one focus on polymerases with multitudinous applications in the field of DNA amplification and sequencing and another one on innovative technologies around protein-protein interactions.
 

Management board & Supervisory board

CEO
Dr. Heikki Lanckriet
Management board
David Roth
Supervisory board
Joseph M. Fernández, Dr. Trevor Jarman, Peter Llewellyn-Davies, Pilar de la Huerta, Tim McCarthy
 

Company data

Name: Expedeon AG
Address: Waldhofer Str. 102,D-69123 Heidelberg
Phone: +49-6221-3540-120
Fax: +49-6221-3540-127
E-mail: info@expedeon.com
Internet: www.expedeon.com
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 63.99%
IPO date: 8/11/2000

Investor relations

Name: -
IR phone: +49-6221-3540-125
IR-Fax: +49-6221-3540-127
IR e-mail: expedeon@mc-services.eu

Company calendar

CW 28 | 7/9/2019 General Shareholder Meeting
CW 32 | 8/8/2019 Interim Report 2nd Quarter/6 Months
CW 45 | 11/7/2019 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
63.99%
Wilhelm K. T. Zour/ Deutsche Balaton
 
8.28%
Fernández Family Trust
 
7.10%
Dero Bank AG
 
4.82%
Dr. Heikki Lanckriet
 
3.17%
Alpenfels Family Trust
 
2.92%
Margarita Salas
 
2.68%
Luis Blanco Davila
 
2.59%
Dievini Hopp BioTech holding GmbH & Co. KG
 
2.56%
Others
 
1.89%